AVN-944

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AVN-944, covering 2011-08-04 to 2011-08-04. Get the full timeline:

Most recent: Clinical Trial Update: Trial of AVN-944 in Patients With Advanced Hematologic Malignancies [Phase 1]